Francisco
Corzana López

2024

1. A family of di-glutamate mucin-degrading enzymes that bridges glycan hydrolases and peptidases

   Nature Catalysis, Vol. 7, Núm. 4, pp. 386-400

2. Correction to: Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase (Nature Communications, (2023), 14, 1, (5785), 10.1038/s41467-023-41238-1)

   Nature Communications

3. Design of glycopeptides for pancreatic cancer detection

   7th Iberian Carbohydrate Meeting: Abstract book

4. Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes

   Angewandte Chemie - International Edition, Vol. 63, Núm. 37

5. Development of therapeutic vaccines based on Tn antigen mimetics

   7th Iberian Carbohydrate Meeting: Abstract book

6. Development of unnatural glycopeptides based on Mucin-1 with diagnostic and therapeutic potential

   6th Regular Network Meeting of the DIRNANO consortium in Salzburg

7. Identification of Tumor-Linked Pancreatic Cancer Autoantibodies in Patients’ sera Through Engineered Glycopeptides

   XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

8. Illuminating a Solvent-Dependent Hierarchy for Aromatic CH/Π Complexes with Dynamic Covalent Glyco-Balances

   7th Iberian Carbohydrate Meeting: Abstract book

9. Illuminating a Solvent-Dependent Hierarchy for Aromatic CH/π Complexes with Dynamic Covalent Glyco-Balances

   JACS Au, Vol. 4, Núm. 2, pp. 476-490

10. Illuminating a Solvent-Dependent Hierarchy for Aromatic CH/π Complexes with Dynamic Covalent Glyco-Balances

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

11. Multivalent carbohydrates systems as antiviral therapueutics

    7th Iberian Carbohydrate Meeting: Abstract book

12. Non-natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

13. Non‐natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity

    Angewandte Chemie International Edition

14. Rational Design of Dual-Domain Binding Inhibitors for N-Acetylgalactosamine Transferase 2 with Improved Selectivity over the T1 and T3 Isoforms

    JACS Au, Vol. 4, Núm. 9, pp. 3649-3656

15. Structure-Based Design of Glycopeptides with Applications in CancerTherapy and Diagnosis

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

16. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au, Vol. 4, Núm. 1, pp. 150-163

17. Synthesis of Tn Antigen β-Mimetics by Photoredox Catalysis

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

18. The Use of Artificial Glycopeptides for Cancer Vaccines and Diagnostic Tools

    31st International Carbohydrate Symposium (ICS2024)

19. The Use of Artificial Glycopeptides for Cancer Vaccines and Diagnostics

    5th Iberoamerican Symposium on Organic Chemistry (SIBEAQO-V)

20. Therapeutic Cancer Vaccines Based on C60 Fullerene and Artificial Glycopeptides

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book